Abbott Laboratories : ABT

All Abbott Laboratories Articles

315 Articles

Douglas A. McIntyre | Mar 20, 2008 at 6:28 AM EDT

Top 10 Pre-Market Analyst Calls (ABT, MO, AMGN, CRME, FNM, FRE, IBN, PNRA, SNDK, ZMH)

These are the top analyst calls we are focusing on early this Thursday morning in pre-market trading: Abbott Laboratories (NYSE:…

Douglas A. McIntyre | Feb 1, 2008 at 12:35 PM EST

FDA’s First Stent Approval Since 2004 (MDT, JNJ, BSX, ABT)

Medtronic, Inc. (NYSE: MDT) has just announced that it has received formal approval from the FDA to market its Endeavor…

Douglas A. McIntyre | Jan 23, 2008 at 7:58 AM EST

Pre-Market Stock News (January 23, 2008)

We are full fledged into earnings season now, so most news coverage will point to the current earnings environment and…

Douglas A. McIntyre | Dec 7, 2007 at 12:12 PM EST

10 CEO’s That Need To Leave in 2008: James Tobin of Boston Scientific (BSX, BIIB, JNJ, ABT)

James Tobin, the CEO of Boston Scientific (NYSE:BSX) is likely to find himself in front of the shareholder firing squad…

Douglas A. McIntyre | Dec 4, 2007 at 6:28 PM EST

Abbott (ABT) Stent Slowdown, Bad For Johnson & Johnson (JNJ) And Boston Scientific (BSX)

Abbott Labs (ABT) which just launched a new stent product, Xience V, has laid off 1,200 people because of slowness…

Douglas A. McIntyre | Nov 30, 2007 at 4:21 AM EST

Media Digest 11/30/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, Fed chief Bernanke said the resurgence in financial strains in recent weeks had dimmed the outlook for…

Douglas A. McIntyre | Nov 29, 2007 at 6:47 PM EST

Bad News For Boston Scientific (BSX) As Abbott (ABT) Moves Closer To Stent Approval

Abbot Labs (ABT) is trying to get into the stent business. The market has been dominated by Boston Scientific (BSX)…

Douglas A. McIntyre | Nov 28, 2007 at 10:18 AM EST

Abbott’s (ABT) Hammers Boston Scientific (BSX)

Boston Scientific (BSX) has been the leader in sales of stents, those little mess tubes that keep arteries open. Recent…

Douglas A. McIntyre | Jul 18, 2007 at 7:15 AM EDT

Pre-Market Stock News (July 18, 2007)

(ABT) Abbott Labs $0.69 EPS vs $0.68 estimate; guidance looks soft.(ASD) American Standard $0.84 EPS net, but $1.05 before items;…

Douglas A. McIntyre | Jul 13, 2007 at 4:58 PM EDT

Top Earnings Next Week Part 1 (July 16-18, 2007)

MONDAYMattel (NYSE:MAT)Novellus (NASDAQ:NVLS)Philips Electronics (NYSE:PHG/ADR)W.W. Grainger (NYSE:GWW) TUESDAYJohnson & Johnson (NYSE:JNJ)Intel Corporation (NASDAQ: INTC)Merrill Lynch (NYSE:MER)Novartis (NYSE:NVS/ADR)Pharmaceutical Product Development (NASDAQ:PPDI)SLM…

Douglas A. McIntyre | Jul 12, 2007 at 5:05 AM EDT

Another Reason Wall St. Hates GE (GE)

GE’s (GE) share price has had a bit of a run over the last three months. Until that point, the…

Douglas A. McIntyre | Jul 12, 2007 at 3:16 AM EDT

Media Digest 7/12/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, Rio Tinto (RTP) has launched a $38.1 billion takeover bid for Alcan (AL). Reuters writes that customers…

Douglas A. McIntyre | Jun 24, 2007 at 12:16 PM EDT

Mixed Short Interest in Drug & Medical Stocks (June 2007)

As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a…

Douglas A. McIntyre | May 30, 2007 at 6:30 PM EDT

Biotechs & Pharmas Bracing For ASCO Annual Meeting

This weekend we have the mother of all future cancer treatment conferences: ASCO, or The American Society of Clinical Oncology. …

Douglas A. McIntyre | May 22, 2007 at 4:36 PM EDT

Short Selling Up in Drug & Medical Stocks

Some sectors showed mixed results in the short selling, but the Big Pharma and medical instruments and related companies saw…

1 … 19 20 21

Abbott Laboratories : ABT

All Abbott Laboratories Articles

Top 10 Pre-Market Analyst Calls (ABT, MO, AMGN, CRME, FNM, FRE, IBN, PNRA, SNDK, ZMH)

FDA’s First Stent Approval Since 2004 (MDT, JNJ, BSX, ABT)

Pre-Market Stock News (January 23, 2008)

10 CEO’s That Need To Leave in 2008: James Tobin of Boston Scientific (BSX, BIIB, JNJ, ABT)

Abbott (ABT) Stent Slowdown, Bad For Johnson & Johnson (JNJ) And Boston Scientific (BSX)

Media Digest 11/30/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Bad News For Boston Scientific (BSX) As Abbott (ABT) Moves Closer To Stent Approval

Abbott’s (ABT) Hammers Boston Scientific (BSX)

Pre-Market Stock News (July 18, 2007)

Top Earnings Next Week Part 1 (July 16-18, 2007)

Another Reason Wall St. Hates GE (GE)

Media Digest 7/12/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Mixed Short Interest in Drug & Medical Stocks (June 2007)

Biotechs & Pharmas Bracing For ASCO Annual Meeting

Short Selling Up in Drug & Medical Stocks

AI XRP Price Prediction: Claude Fable 5 Predicts the XRP Price for End of 2026

The Monthly Income Trap: How JEPQ Investors Gave Up $18,000 Per $10,000 Invested Since Inception

‘The Borrower Is Slave to the Lender’: Dave Ramsey Warns a 22-Year-Old Against Letting a Rich Friend Pay Off His $70,000 Debt

'The Borrower Is Slave to the Lender': Dave Ramsey Warns a 22-Year-Old Against Letting a Rich Friend Pay Off His $70,000 Debt

$1 Million in Retirement Savings Spends Like $40,000 a Year. Here's Why That's Not Enough.

AI XRP Price Prediction: Claude Fable 5 Predicts the XRP Price for End of 2026

The Monthly Income Trap: How JEPQ Investors Gave Up $18,000 Per $10,000 Invested Since Inception

Abbott Laboratories : ABT

All Abbott Laboratories Articles

Top 10 Pre-Market Analyst Calls (ABT, MO, AMGN, CRME, FNM, FRE, IBN, PNRA, SNDK, ZMH)

FDA’s First Stent Approval Since 2004 (MDT, JNJ, BSX, ABT)

Pre-Market Stock News (January 23, 2008)

10 CEO’s That Need To Leave in 2008: James Tobin of Boston Scientific (BSX, BIIB, JNJ, ABT)

Abbott (ABT) Stent Slowdown, Bad For Johnson & Johnson (JNJ) And Boston Scientific (BSX)

Media Digest 11/30/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Bad News For Boston Scientific (BSX) As Abbott (ABT) Moves Closer To Stent Approval

Abbott’s (ABT) Hammers Boston Scientific (BSX)

Pre-Market Stock News (July 18, 2007)

Top Earnings Next Week Part 1 (July 16-18, 2007)

Another Reason Wall St. Hates GE (GE)

Media Digest 7/12/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Mixed Short Interest in Drug & Medical Stocks (June 2007)

Biotechs & Pharmas Bracing For ASCO Annual Meeting

Short Selling Up in Drug & Medical Stocks

AI XRP Price Prediction: Claude Fable 5 Predicts the XRP Price for End of 2026

The Monthly Income Trap: How JEPQ Investors Gave Up $18,000 Per $10,000 Invested Since Inception

‘The Borrower Is Slave to the Lender’: Dave Ramsey Warns a 22-Year-Old Against Letting a Rich Friend Pay Off His $70,000 Debt

Featured Reads

'The Borrower Is Slave to the Lender': Dave Ramsey Warns a 22-Year-Old Against Letting a Rich Friend Pay Off His $70,000 Debt

$1 Million in Retirement Savings Spends Like $40,000 a Year. Here's Why That's Not Enough.